Veterinary Medicines

Utertab 2000 mg intrauterine tablet for cattle

Authorised
  • Tetracycline hydrochloride
Download as PDF

Product identification

Medicine name:
Utertab 2000 mg intrauterine tablet for cattle
Utertab 2000 mg
Active substance:
  • Tetracycline hydrochloride
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intrauterine use

Product details

Active substance and strength:
  • Tetracycline hydrochloride
    2000.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Intrauterine tablet
Withdrawal period by route of administration:
  • Intrauterine use
    • Cattle (lactating cow)
      • Milk
        96
        hour
      • Meat and offal
        10
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • (ID9) 500 Intrauterine tablet: unspecified outer container with 100 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID8) 400 Intrauterine tablet: unspecified outer container with 80 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID7) 300 Intrauterine tablet: unspecified outer container with 60 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID6) 200 Intrauterine tablet: unspecified outer container with 40 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID5) 100 Intrauterine tablet: unspecified outer container with 20 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID4) 50 Intrauterine tablet: unspecified outer container with 10 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID3) 20 Intrauterine tablet: unspecified outer container with 4 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID2) 10 Intrauterine tablet: unspecified outer container with 2 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Animedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Animedica GmbH
  • Animedica Herstellungs GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402466.00.00
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0176/001
Concerned member states:
  • Bulgaria
  • Croatia
  • Hungary
  • Ireland
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (RTF)
Published on: 15/01/2024
Download

2402466-paren-20181009.rtf

English (RTF)
Published on: 15/01/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."